BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 387959)

  • 1. Immune complexes in newly diagnosed insulin-dependent (type I) diabetics.
    Irvine WJ; Di Mario U; Guy K; Feek CM; Gray RS; Duncan LJ
    J Clin Lab Immunol; 1978 Nov; 1(3):183-6. PubMed ID: 387959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immunity in type 1 diabetes mellitus: a prospective study.
    Borsey DQ; Di Mario U; Irvine WJ; Gray RS; Guy K; Weston J; Peutherer J; Duncan LJ
    J Clin Lab Immunol; 1983 May; 11(1):9-15. PubMed ID: 6876143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in type I diabetics with persistent islet cell antibodies.
    Irvine WJ; Di Mario U; Guy K; Borsey DQ
    J Clin Lab Immunol; 1980 Sep; 4(2):87-9. PubMed ID: 7003148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complexes and diabetic microangiopathy.
    Irvine WJ; Di Mario U; Guy K; Iavicoli M; Pozzilli P; Lumbroso B; Andreani D
    J Clin Lab Immunol; 1978 Nov; 1(3):187-91. PubMed ID: 756468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of islet cell antibody in predicting secondary failure of oral hypoglycaemic agent therapy in Diabetes mellitus.
    Irvine WJ; Sawers JS; Feek CM; Prescott RJ; Duncan LJ
    J Clin Lab Immunol; 1979 Apr; 2(1):23-6. PubMed ID: 95802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes in old people and in diabetics: correlation with autoantibodies.
    Delespesse G; Gausset P; Sarfati M; Dubi-Rucquoy M; Debisschop MJ; van Haelst L
    Clin Exp Immunol; 1980 Apr; 40(1):96-102. PubMed ID: 6993080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New evidence of circulating immune complexes in Crohn's disease using two sensitive methods.
    Pallone F; Montano S; Ricci R; Iavicoli M; Di Mario U
    J Clin Lab Immunol; 1981 Jan; 5(1):23-5. PubMed ID: 7218324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.
    Irvine WJ; Al-Khateeb SF; Di Mario U; Feek CM; Gray RS; Edmond B; Duncan LJ
    Clin Exp Immunol; 1977 Oct; 30(1):16-21. PubMed ID: 606435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet cell antibodies and diabetes in Nigerians.
    Oli JM; Bottazzo GF; Doniach D
    Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes in diabetics: the influence of sex, age, duration of disease and type of treatment.
    Di Mario U; Irvine WJ; Guy K; Borsey DQ; Iavicoli M; Ventriglia L
    J Clin Lab Immunol; 1983 May; 11(1):17-20. PubMed ID: 6348294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Islet cell antibodies in diabetes mellitus (author's transl)].
    Pujol-Borrell R; Richart C
    Med Clin (Barc); 1980 Mar; 74(5):163-9. PubMed ID: 6991837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in diabetics with severe microangiopathy: evaluation by two different methods.
    Andreani D; Di Mario U; Galfo C; Ventriglia L; Iavicoli M
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):239-44. PubMed ID: 7036632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Auto-immunity and insulin-dependent diabetes].
    Vialettes B; Beaume D; Vague P
    Diabete Metab; 1982 Dec; 8(4):349-55. PubMed ID: 6761189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents.
    Irvine WJ; McCallum CJ; Gray RS; Duncan LJ
    Lancet; 1977 May; 1(8020):1025-7. PubMed ID: 67485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
    Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population survey of pancreatic islet cell antibodies.
    Rodger B; Whittingham S; Martin FI; Hawkins BR; Dawkins RL; Welborn TA
    Clin Exp Immunol; 1980 Jan; 39(1):125-9. PubMed ID: 6993063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New findings on the pathogenesis of diabetes mellitus].
    Keller U
    Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of pancreatic islet cell antibody and abnormal glucose tolerance during pregnancy.
    Steel JM; Irvine WJ; Clarke BF
    J Clin Lab Immunol; 1980 Sep; 4(2):83-5. PubMed ID: 7003147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.